/

Other

/

Megalabs

Megalabs

Megalabs

Verified Nov 2026

Other

·

·

Since 2002

Megalabs is a pharmaceutical conglomerate founded in 2002 and headquartered in Canelones, Uruguay, with 5,000-10,000 employees and estimated revenue between $1-5 billion. The company manufactures and distributes over 1,800 medications, dermo-cosmetics, and nutritional supplements across 18 manufacturing plants serving markets in Latin America and the Caribbean. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors, and recently secured $420 million in financing while acquiring operations in Argentina and North America.

Megalabs

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

Employees

5,000-10,000

Ownership

Megalabs at a glance

Revenue

$1-5B

Est. band

Employees

5,000-10,000

Founded

2002

Certifications

ISO 13485

Import activity

85

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

85

Named foreign suppliers

13

Top origins

Chile · Belgium · Dominican Republic · Spain

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Megalabs.

What this tells a buyer

Megalabs received 85 recorded shipments from multiple origins including Chile, Germany, Dominican Republic, Belgium, and Mexico, with Dr Willmar Schwabe (Germany) accounting for 94 shipments.

The company holds ISO 13485 certification and manufactures bioequivalent drugs, generic medications, and therapeutic products across cardiology, pediatrics, oncology, dermatology, and other medical specialties.

Megalabs operates 18 manufacturing facilities and serves Latin American and Caribbean markets with a portfolio exceeding 1,800 products addressing diverse therapeutic areas including women's health, pain management, and infectious disease treatment.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

24 years in operation (founded 2002).

85 US import shipments on record.

Holds ISO 13485 certification(s) per public sources.

Overview

Megalabs is a pharmaceutical conglomerate founded in 2002 and headquartered in Canelones, Uruguay, with 5,000-10,000 employees and estimated revenue between $1-5 billion. The company manufactures and distributes over 1,800 medications, dermo-cosmetics, and nutritional supplements across 18 manufacturing plants serving markets in Latin America and the Caribbean. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors, and recently secured $420 million in financing while acquiring operations in Argentina and North America.

At a glance

Attribute

Detail

Founded

2002

Employees

5,000-10,000

Revenue

$1-5B (estimated)

Certifications

ISO 13485

What Megalabs makes

The company holds ISO 13485 certification and manufactures bioequivalent drugs, generic medications, and therapeutic products across cardiology, pediatrics, oncology, dermatology, and other medical specialties.

Certifications

Megalabs is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Megalabs received 85 recorded shipments from multiple origins including Chile, Germany, Dominican Republic, Belgium, and Mexico, with Dr Willmar Schwabe (Germany) accounting for 94 shipments. US customs bill-of-lading records list 85 inbound shipments across 13 foreign suppliers, with top origins including Chile · Belgium · Dominican Republic · Spain.

Latest developments

Company details

Megalabs operates 18 manufacturing facilities and serves Latin American and Caribbean markets with a portfolio exceeding 1,800 products addressing diverse therapeutic areas including women's health, pain management, and infectious disease treatment. Megalabs was founded in 2002, and has an estimated 5,000-10,000 employees. On the LightSource stability read it is rated "Established & active": 24 years in operation (founded 2002). 85 US import shipments on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Megalabs do?

Megalabs is a pharmaceutical conglomerate founded in 2002 and headquartered in Canelones, Uruguay, with 5,000-10,000 employees and estimated revenue between $1-5 billion. The company manufactures and distributes over 1,800 medications, dermo-cosmetics, and nutritional supplements across 18 manufacturing plants serving markets in Latin America and the Caribbean. It serves automotive, electric-vehicle, medical, and industrial-equipment sectors, and recently secured $420 million in financing while acquiring operations in Argentina and North America.

When was Megalabs founded?

Megalabs was founded in 2002.

How big is Megalabs?

Megalabs has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).

What certifications does Megalabs hold?

Megalabs lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Does Megalabs import from overseas suppliers?

US customs bill-of-lading records show 85 inbound shipments for Megalabs, with top origins including Chile · Belgium · Dominican Republic · Spain.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Departamento de CanelonesHeadquarters · Uruguay
Departamento de CanelonesCap. Juan Antonio Artigas, Departamento de Canelones, 14000, UruguayHeadquarters

Phone

'+598 2683 8000

Certification

ISO 13485

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.